AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study

Recent trial results, however, indicate that Ubrelvy holds the potential to prevent migraines when used in reaction to their warning signs. In a study published this week in the journal Neurology, Ubrelvy was 73% more effective in preventing a migraine attack than a placebo.